NBIX
Neurocrine Biosciences Inc
Price:  
152.42 
USD
Volume:  
783,501.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NBIX WACC - Weighted Average Cost of Capital

The WACC of Neurocrine Biosciences Inc (NBIX) is 7.6%.

The Cost of Equity of Neurocrine Biosciences Inc (NBIX) is 7.70%.
The Cost of Debt of Neurocrine Biosciences Inc (NBIX) is 4.25%.

Range Selected
Cost of equity 6.50% - 8.90% 7.70%
Tax rate 23.10% - 26.00% 24.55%
Cost of debt 4.00% - 4.50% 4.25%
WACC 6.5% - 8.8% 7.6%
WACC

NBIX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.57 0.71
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.50% 8.90%
Tax rate 23.10% 26.00%
Debt/Equity ratio 0.01 0.01
Cost of debt 4.00% 4.50%
After-tax WACC 6.5% 8.8%
Selected WACC 7.6%